Taligantinib

SKU: orb3135903

Description

Taligantinib (Compound Example 70) is an orally active and selective dual inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2) and hepatocyte growth factor receptor (c-Met). It effectively suppresses tumor angiogenesis and cell proliferation, and holds potential for the study of solid tumors such as non-small cell lung cancer and hepatocellular carcinoma.

Research Area

Cardiovascular Research, Signal Transduction

Key Properties

• CAS Number: 2243235-80-3
• MW: 660.66
• Formula: C₃₅H₃₄F₂N₄O₇
• SMILES: O=C(NC1=CC=C(F)C=C1)C2(C(=O)NC3=CC=C(OC4=CC=NC5=CC(OCCCN6CCOCC6)=C7OCCOC7=C54)C(F)=C3)CC2
• Target: c-Met/HGFR,VEGFR

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

c-Met/HGFR,VEGFR